NASDAQ
Eupraxia Pharmaceuticals Inc. (EPRXF) has a free cash flow growth of -27.72% as of Friday, May 29, 2026. This represents a 85.06% increase compared to its 12-month average of -185.46%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.